You have been treated for IBS, but your nausea has not improved. The early satiety persists. You still feel like food sits in your stomach for hours after eating. The low-FODMAP diet helped your lower GI symptoms somewhat, but the upper abdominal fullness, the nausea, and the inability to eat full meals remain unchanged. This is the clinical scenario in which gastroparesis testing becomes a high-value next step. Gastric emptying studies are not part of the IBS workup, so the test will not happen unless you or your doctor specifically requests it. This guide covers which tests are available, how they work, what the results mean, and what treatment looks like if gastroparesis is confirmed.
When should you ask for gastroparesis testing?
Gastroparesis testing is warranted when IBS treatments have failed to address upper GI symptoms after at least 3-6 months of consistent effort. Specific indicators include nausea that is your primary or most bothersome symptom and has not responded to IBS management, early satiety that limits your ability to eat normal-sized meals, a sensation of food sitting in your stomach for hours after eating (postprandial fullness), bloating that is concentrated in the upper abdomen or epigastric area, symptoms that are consistently worse with solid foods but better with liquids, unintentional weight loss related to inability to eat adequate amounts, and vomiting of undigested food hours after eating.
Before ordering a gastric emptying study, your doctor will typically perform or confirm an upper endoscopy (EGD) to rule out mechanical obstruction. Pyloric stenosis, gastric outlet obstruction, and other structural causes must be excluded because these require different treatment than gastroparesis. If your EGD is normal and your upper GI symptoms persist despite IBS treatment, a gastric emptying study is the next logical step.
The 4-hour gastric emptying scintigraphy protocol
Gastric emptying scintigraphy (GES) is the gold standard diagnostic test for gastroparesis. The standardized protocol established by the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine involves a specific meal and imaging schedule.
The test meal
The standardized meal consists of Egg Beaters (or equivalent liquid egg whites, 120 mL) scrambled and labeled with technetium-99m sulfur colloid (0.5-1.0 mCi), two slices of white bread, strawberry jam (30 g), and water (120 mL). This meal provides approximately 255 kcal with 72% carbohydrate, 24% protein, 2% fat, and 2% fiber. The low fat content is intentional because fat slows gastric emptying, and a high-fat test meal could produce false-positive results. You must eat the entire meal within 10 minutes for the test to be valid.
Imaging schedule
After eating, you stand or sit in front of a gamma camera that detects the radioactive tracer in your stomach. Images are taken at 0, 1, 2, and 4 hours. Each imaging session takes approximately 1-2 minutes. Between imaging sessions, you can sit in a waiting area but should not eat, drink, or exercise (physical activity affects gastric emptying rates). The total time commitment is approximately 4.5 hours from when you start eating to the final image. You must remain at the facility for the duration.
Preparation requirements
- Fast for at least 8 hours (overnight) before the test. No food or liquids after midnight if your test is in the morning.
- Discuss medication adjustments with your doctor. Medications that affect gastric motility should be held before the test: prokinetics (metoclopramide, domperidone, erythromycin) for at least 48-72 hours, opioid pain medications for at least 48 hours, anticholinergic medications for 48 hours, and GLP-1 receptor agonists per your prescriber's guidance (these can significantly delay emptying).
- Continue diabetes medications and insulin as directed by your endocrinologist. Hyperglycemia (blood glucose above 275 mg/dL) can delay gastric emptying independently, so good glycemic control before the test is important for accurate results.
- Do not smoke the morning of the test. Smoking accelerates gastric emptying and can produce false-negative results.
- Avoid vigorous exercise the morning of the test, as physical activity affects gastric motility.
â ī¸If you cannot eat the full test meal within 10 minutes, or if you vomit during the study, tell the technologist immediately. Incomplete meal consumption or vomiting affects result accuracy. Your doctor may need to adjust the interpretation or reschedule the test.
How to interpret gastric emptying results
Results are reported as the percentage of meal retained in the stomach at each time point. Normal gastric emptying shows less than 90% retention at 1 hour, less than 60% retention at 2 hours, and less than 10% retention at 4 hours. The 4-hour time point is the most important. More than 10% retention at 4 hours is the diagnostic threshold for gastroparesis.
Severity grading based on 4-hour retention
- Mild gastroparesis: 11-20% retention at 4 hours. These patients often respond well to dietary modification and may not require prokinetic medications.
- Moderate gastroparesis: 21-35% retention at 4 hours. Dietary changes plus prokinetic therapy are typically needed.
- Severe gastroparesis: more than 35% retention at 4 hours. These patients often require aggressive medical management, may need nutritional support, and are candidates for interventional procedures if medications fail.
Pay attention to the study duration. If your facility only performed a 90-minute or 2-hour study, a normal result does not confidently rule out gastroparesis. Tougas and colleagues demonstrated that approximately 30% of patients with delayed emptying at 4 hours had normal results at 2 hours. If your shortened study was normal but your symptoms strongly suggest gastroparesis, discuss repeating with the full 4-hour protocol.
SmartPill wireless motility capsule
The SmartPill is an FDA-cleared alternative to scintigraphy for evaluating gastric emptying. It is an ingestible capsule (26 mm x 13 mm) that contains sensors measuring pH, pressure, and temperature as it travels through the entire GI tract. The capsule transmits data wirelessly to a receiver worn on your belt or placed nearby. The transition from the acidic stomach environment to the alkaline duodenum produces a characteristic pH shift that marks gastric emptying time. The SmartPill defines delayed gastric emptying as a gastric emptying time greater than 5 hours.
The SmartPill has several advantages over scintigraphy. It does not involve radiation exposure. It measures motility throughout the entire GI tract (stomach, small intestine, and colon), providing information about whole-gut transit. It is performed as an outpatient procedure. Disadvantages include higher cost, the inability to measure real-time meal emptying patterns, contraindication in patients with known strictures or obstruction, and the fact that the capsule must be recovered and the data downloaded. Kuo and colleagues demonstrated good correlation between SmartPill gastric emptying time and scintigraphy results, though the two tests use different metrics and thresholds.
| Feature | Scintigraphy (GES) | SmartPill |
|---|---|---|
| Gold standard? | Yes | FDA-cleared alternative |
| Radiation exposure | Low-dose (technetium-99m) | None |
| Duration | 4 hours at facility | Capsule worn 3-5 days |
| Gastric emptying threshold | >10% retention at 4 hours | >5 hours gastric emptying time |
| Whole-gut transit data | No | Yes |
| Approximate cost | $500-1500 | $800-2000 |
| Contraindications | Pregnancy | Known strictures, obstruction, implanted devices |
Prokinetic agents: what the options are
If gastroparesis is confirmed, prokinetic medications may be prescribed to improve gastric emptying. The available options each have distinct efficacy and safety profiles.
- Metoclopramide (Reglan). The only FDA-approved prokinetic for gastroparesis in the United States. Dose is typically 5-10 mg taken 30 minutes before meals and at bedtime. It works by blocking dopamine D2 receptors and has both prokinetic and antiemetic effects. The significant limitation is a black box warning for tardive dyskinesia (involuntary movements) with use beyond 12 weeks. Regular reassessment is required.
- Domperidone. A dopamine D2 antagonist similar to metoclopramide but with less central nervous system penetration, meaning lower risk of tardive dyskinesia. Not FDA-approved in the United States but available through the FDA's expanded access program (IND protocol). Widely used in Canada, Europe, and other countries. Requires an ECG before starting due to QT prolongation risk.
- Low-dose erythromycin. An antibiotic that at low doses (50-100 mg before meals) acts as a motilin receptor agonist, stimulating gastric contractions. Effective in the short term but tachyphylaxis (reduced response over time) is common. Typically used as a bridge therapy or for acute exacerbations rather than long-term management. Risk of antibiotic resistance with chronic use.
- Prucalopride. A selective serotonin 5-HT4 receptor agonist approved for chronic constipation. Some evidence supports its use for gastroparesis, though this is off-label. It has a better safety profile than metoclopramide for long-term use.
Diet modifications for confirmed gastroparesis
Dietary management is a cornerstone of gastroparesis treatment and differs substantially from IBS dietary advice. The goals are to reduce the mechanical work the stomach must do to empty food and to maintain adequate nutrition despite reduced capacity.
- Eat small, frequent meals. Four to six small meals per day rather than three large ones. Smaller volume means less gastric distension and faster emptying.
- Reduce dietary fat. Fat slows gastric emptying in everyone. In gastroparesis, high-fat meals exacerbate delayed emptying significantly. Aim for less than 40 grams of fat per day as a starting point.
- Reduce dietary fiber. Fiber, particularly insoluble fiber from raw vegetables, whole grains, and skins, forms bezoars (compacted masses) in a stomach that does not empty properly. Low-fiber choices (white bread, white rice, peeled and cooked vegetables, canned fruit) are preferred.
- Emphasize liquids and soft solids. Liquid gastric emptying is often preserved even when solid emptying is severely delayed. Smoothies, soups, pureed foods, and well-cooked soft foods are better tolerated than raw, fibrous, or tough-textured foods.
- Stay upright after eating. Remaining upright (seated or standing) for 1-2 hours after meals uses gravity to assist gastric emptying. Lying down after eating can worsen symptoms.
- Chew thoroughly. Mechanical breakdown of food in the mouth reduces the work the stomach must do. Take time with meals and chew each bite to a smooth consistency before swallowing.
âšī¸Note that the gastroparesis diet (low-fiber, low-fat, small portions) can conflict with a low-FODMAP diet (which restricts certain carbohydrates but does not restrict fiber or fat specifically). If you have been on a low-FODMAP diet for IBS and gastroparesis is confirmed, your dietary strategy will likely need to be adjusted. Work with a dietitian experienced in gastroparesis to develop a sustainable eating plan.
What helps with tracking symptoms during testing
The period before and after gastroparesis testing is important to document. Your doctor will interpret test results alongside your symptom history, particularly the relationship between symptoms and meal composition, timing, and portion size. Record what you eat, meal size, time of eating, and when symptoms appear. Track nausea severity, fullness duration, and any episodes of vomiting. Note whether liquids are tolerated better than solids. The GLP1Gut app can streamline this documentation by logging meals and symptoms in a format you can share directly with your gastroenterologist, giving them context that a single-day test cannot capture.
What to expect from the diagnostic process
The path from requesting a gastroparesis evaluation to confirmed diagnosis typically involves several steps. Your gastroenterologist will review your symptom history and confirm that upper GI symptoms (nausea, early satiety, postprandial fullness) are prominent. An upper endoscopy will be performed or confirmed to rule out mechanical obstruction. Medications affecting gastric motility will be adjusted or held before testing. The gastric emptying study will be scheduled and performed. Results are typically available within 1-3 days for scintigraphy. If positive, a treatment plan combining dietary modification and possibly prokinetics will be developed. If borderline or negative but symptoms are suggestive, the SmartPill or repeat scintigraphy may be considered.
Frequently Asked Questions
How much does a gastric emptying study cost?
Gastric emptying scintigraphy typically costs $500-1500 depending on the facility and your insurance. The SmartPill costs $800-2000. Most insurance plans cover scintigraphy when ordered by a gastroenterologist with appropriate clinical indication. SmartPill coverage is less consistent. Check with your insurer before scheduling.
Is the radiation from scintigraphy dangerous?
The radiation dose from a gastric emptying scintigraphy is low, approximately equivalent to a standard chest X-ray. It uses technetium-99m, which has a short half-life (6 hours) and is eliminated from the body quickly. The test is not recommended during pregnancy. For most patients, the diagnostic benefit significantly outweighs the minimal radiation risk.
Can I take my regular medications the day of the test?
Essential medications (blood pressure, thyroid, psychiatric) can generally be taken with a small sip of water on the morning of the test. Medications that affect gastric motility (prokinetics, opioids, anticholinergics, GLP-1 agonists) must be held for 48-72 hours before testing, as they can produce inaccurate results. Always confirm the specific medication plan with your ordering physician.
What if my gastric emptying study is normal but I still have symptoms?
A normal gastric emptying study rules out gastroparesis but does not explain your symptoms. Functional dyspepsia, which has overlapping symptoms, is diagnosed clinically and does not require delayed emptying. Other possibilities include gastroparesis that was not captured due to day-to-day variability, SIBO, bile acid malabsorption, or superior mesenteric artery syndrome. Discuss next steps with your gastroenterologist.
How long do I need to be on a gastroparesis diet?
Dietary management for gastroparesis is typically long-term, as the underlying motility dysfunction is usually chronic. Some patients with post-viral gastroparesis may be able to liberalize their diet as motility improves over months to years. The gastroparesis diet is not meant to be temporary. Work with a dietitian to ensure nutritional adequacy while managing symptoms.
â ī¸This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition.